Rapid label-free visual assay for the detection and quantification of viral RNA using peptide nucleic acid (PNA) and gold nanoparticles (AuNPs).

A rapid label-free visual assay for the detection of viral RNA using peptide nucleic acid (PNA) probes and gold nanoparticles (AuNPs) is presented in this study. Diagnosis is a crucial step for the molecular surveillance of diseases, and a rapid visual test with high specificity could play a vital role in the management of viral diseases. In this assay, the specific agglomerative behavior of PNA with gold nanoparticles was manipulated by its complementation with viral RNA. The assay was able to detect 5-10 ng of viral RNA from various biological samples, such as allantoic fluids, cell culture fluids and vaccines, in 100 μl of test solution. The developed assay was more sensitive than a hemagglutination (HA) test, a routine platform test for the detection of Newcastle disease virus (NDV), and the developed assay was able to visually detect NDV with as little as 0.25 HA units of virus. In terms of the specificity, the test could discriminate single nucleotide differences in the target RNA and hence could provide visual viral genotyping/pathotyping. This observation was confirmed by pathotyping different known isolates of NDV. Further, the PNA-induced colorimetric changes in the presence of the target RNA at different RNA to PNA ratios yielded a standard curve with a linear coefficient of R(2)=0.990, which was comparable to the value of R(2)=0.995 from real-time PCR experiments with the same viral RNA. Therefore, the viral RNA in a given samples could be quantified using a simple visual spectrophotometer available in any clinical laboratory. This assay may find application in diagnostic assays for other RNA viruses, which are well known to undergo mutations, thus presenting challenges for their molecular surveillance, genotyping and quantification.

[1]  K. Jain,et al.  Nanotechnology in clinical laboratory diagnostics. , 2005, Clinica chimica acta; international journal of clinical chemistry.

[2]  Remo Guidieri Res , 1995, RES: Anthropology and Aesthetics.

[3]  P. Jain,et al.  Calculated absorption and scattering properties of gold nanoparticles of different size, shape, and composition: applications in biological imaging and biomedicine. , 2006, The journal of physical chemistry. B.

[4]  R. Kataria,et al.  Pathotyping of Newcastle Disease Viruses by RT-PCR and Restriction Enzyme Analysis , 2000, Veterinary Research Communications.

[5]  P. Nielsen,et al.  Unique properties of purine/pyrimidine asymmetric PNA.DNA duplexes: differential stabilization of PNA.DNA duplexes by purines in the PNA strand. , 2006, Biophysical journal.

[6]  Peter Eaton,et al.  Gold nanoparticles for the development of clinical diagnosis methods , 2008, Analytical and bioanalytical chemistry.

[7]  Hui Chen,et al.  A one-step homogeneous immunoassay for cancer biomarker detection using gold nanoparticle probes coupled with dynamic light scattering. , 2008, Journal of the American Chemical Society.

[8]  R. Deb,et al.  Functionalizing gold nanoparticles with bluetongue virus multiple peptide antigens utilizing gold-thiol interaction: a novel approach to develop pen side test. , 2012, Research in veterinary science.

[9]  R. G. Freeman,et al.  Preparation and Characterization of Au Colloid Monolayers , 1995 .

[10]  Xiaodi Su,et al.  Colorimetric detection of DNA using unmodified metallic nanoparticles and peptide nucleic acid probes. , 2009, Analytical chemistry.

[11]  R. Kataria,et al.  Sequence analysis of the cleavage site-encoding region of the fusion protein gene of Newcastle disease viruses from India and Nepal , 2000, Avian pathology : journal of the W.V.P.A.

[12]  Weihong Tan,et al.  Aptamer-modified gold nanoparticles for colorimetric determination of platelet-derived growth factors and their receptors. , 2005, Analytical chemistry.

[13]  X. Su,et al.  Control of metal nanoparticles aggregation and dispersion by PNA and PNA-DNA complexes, and its application for colorimetric DNA detection. , 2009, ACS nano.

[14]  C. Tseng,et al.  Antigenic and genotypical characterization of Newcastle disease viruses isolated in Taiwan between 1969 and 1996. , 2004, Veterinary microbiology.

[15]  P. Baptista,et al.  Gold-nanoparticle-probe-based assay for rapid and direct detection of Mycobacterium tuberculosis DNA in clinical samples. , 2006, Clinical chemistry.

[16]  M. Egholm,et al.  Evidence for (PNA)2/DNA triplex structure upon binding of PNA to dsDNA by strand displacement , 1994, Journal of molecular recognition : JMR.

[17]  R. Kataria,et al.  Differential detection of Newcastle disease virus strains by degenerate primers based RT-PCR. , 2004, Comparative immunology, microbiology and infectious diseases.

[18]  J. Hoheisel,et al.  Hybridisation based DNA screening on peptide nucleic acid (PNA) oligomer arrays. , 1997, Nucleic acids research.

[19]  Pedro V Baptista,et al.  RNA quantification using gold nanoprobes - application to cancer diagnostics , 2010, Journal of nanobiotechnology.

[20]  Y. Nagai Virus Activation by Host Proteinases. A Pivotal Role in the Spread of Infection, Tissue Tropism and Pathogenicity , 1995, Microbiology and immunology.

[21]  W. H. Allan,et al.  Newcastle disease virus pathotypes. , 1974, Avian pathology : journal of the W.V.P.A.